Aegerion Pharmaceuticals (Nasdaq: AEGR) announced that it has received a closeout letter from the Office of Prescription Drug Promotion (OPDP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE